Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.425ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.425NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.354ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.354ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.354NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.503ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.503ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.503ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.503NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.623ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.623ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.623ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.623NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.214.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.214.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.588ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.588ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.588ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.588NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.210ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.210ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.210NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.567ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.567ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.567ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.567NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.541ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.541ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used